Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Keros Therapeutics, Inc. (KROS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Regnante Keith (CFO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 17,301 shares
@ $47.66, valued at
$824.6k
Sold 2,699 shares
@ $48.65, valued at
$131.3k
Sold 15,993 shares
@ $45.03, valued at
$720.2k
Sold 1,428 shares
@ $46.46, valued at
$66.3k
Sold 2,579 shares
@ $47.25, valued at
$121.9k
Exercised 20,000 options to buy
@ $16, valued at
$320k
Exercised 20,000 options to buy
@ $16, valued at
$320k
|
|
| 06/08/2023 |
4
| GORDON CARL L (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| Seth Alpna (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| Kariv Tomer (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 06/08/2023 |
4
| Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $48.79, valued at
$487.9k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
3
| Seth Alpna (Director) has filed a Form 3 on Keros Therapeutics, Inc. |
| 01/20/2023 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Bought 1,191 shares
@ $20.98, valued at
$25k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,539 options to buy
@ $0.0001, valued at
$0.4
Exercised (in-or-at-the-money) 1,723 options to buy
@ $0.0001, valued at
$0.2
Exercised (in-or-at-the-money) 1,914 options to buy
@ $0.0001, valued at
$0.2 |
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 11/30/2022 |
3/A
| Nussbaum Ran (10% Owner) has filed a Form 3/A on Keros Therapeutics, Inc. |
| 11/30/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 07/19/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 46,034 shares
@ $30, valued at
$1.4M
Exercised 46,034 options to buy
@ $0.3, valued at
$13.8k
|
|
| 07/15/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,916 shares
@ $30, valued at
$57.5k
Exercised 1,916 options to buy
@ $0.3, valued at
$574.8 |
|
| 06/14/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Exercised 9,400 options to buy
@ $0.3, valued at
$2.8k
|
|
| 06/10/2022 |
4
| Seehra Jasbir (CEO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0.3, valued at
$1.5k
|
|
| 06/03/2022 |
4
| Nussbaum Ran (10% Owner) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,293 options to buy
@ $32.95, valued at
$273.3k
|
|
| 06/03/2022 |
4
| Knowles Julius (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,293 options to buy
@ $32.95, valued at
$273.3k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Farzan Nima (Director) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 8,293 options to buy
@ $32.95, valued at
$273.3k
|
|
| 05/13/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 3,398 shares
@ $41.26, valued at
$140.2k
Sold 944 shares
@ $42.49, valued at
$40.1k
Sold 719 shares
@ $43.32, valued at
$31.1k
Sold 223 shares
@ $44.23, valued at
$9.9k
Sold 16 shares
@ $45.45, valued at
$727.2
Exercised 5,300 options to buy
@ $0.3, valued at
$1.6k
|
|
| 04/13/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,417 shares
@ $61.37, valued at
$87k
Sold 1,009 shares
@ $62.32, valued at
$62.9k
Sold 2,315 shares
@ $63.5, valued at
$147k
Sold 559 shares
@ $64.15, valued at
$35.9k
Exercised 5,300 options to buy
@ $0.3, valued at
$1.6k
|
|
| 04/08/2022 |
4
| Rovaldi Christopher (COO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,728 shares
@ $65, valued at
$112.3k
Exercised 1,728 options to buy
@ $16, valued at
$27.6k
|
|
| 04/06/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 7,950 shares
@ $60, valued at
$477k
Exercised 7,950 options to buy
@ $0.3, valued at
$2.4k
|
|
| 04/05/2022 |
4
| Rovaldi Christopher (COO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 2 shares
@ $54.34, valued at
$108.7
Sold 104 shares
@ $56.2, valued at
$5.8k
Sold 287 shares
@ $56.89, valued at
$16.3k
Sold 366 shares
@ $57.97, valued at
$21.2k
Sold 105 shares
@ $58.83, valued at
$6.2k
Exercised 864 options to buy
@ $16, valued at
$13.8k
|
|
| 03/15/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,062 shares
@ $52.43, valued at
$55.7k
Sold 713 shares
@ $53.36, valued at
$38k
Sold 875 shares
@ $54.54, valued at
$47.7k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
| 02/15/2022 |
4
| Lachey Jennifer (Chief Scientific Officer) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 1,073 shares
@ $51.5, valued at
$55.3k
Sold 1,378 shares
@ $52.35, valued at
$72.1k
Sold 199 shares
@ $53.1, valued at
$10.6k
Exercised 2,650 options to buy
@ $0.3, valued at
$795 |
|
|
|
|